Neuronal functions and emerging pharmacology of TAAR1

Topics in Medicinal Chemistry

Volumn 23, Issue , 2017, Pages 175-194

  Espinoza, Stefano ^a   Gainetdinov, Raul R ^a,b,c  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPAMINE; AMINO ACID DECARBOXYLASE; AMPHETAMINE; CATECHOL METHYLTRANSFERASE; CYCLIC AMP; DOPAMINE; G PROTEIN COUPLED RECEPTOR; NORADRENALIN; PHENETHYLAMINE; RNA; SEROTONIN; TRACE AMINE ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BIPOLAR DISORDER; BRAIN FUNCTION; CELLULAR DISTRIBUTION; CHROMOSOME 6; CONCENTRATION (PARAMETERS); DECARBOXYLATION; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG TARGETING; EC50; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; INTRACELLULAR SPACE; MENTAL DISEASE; MONOAMINERGIC SYSTEM; NERVE FUNCTION; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PSEUDOGENE; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; TISSUE DISTRIBUTION; VENTRAL TEGMENTUM;

EID: 85008366306     PISSN: 18622461     EISSN: 1862247X     Source Type: Book Series    
DOI: 10.1007/7355_2014_78     Document Type: Article

References (89)

1. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, Durkin MM, Lakhlani PP, Bonini JA, Pathirana S, Boyle N, Pu X, Kouranova E, Lichtblau H, Ochoa FY, Branchek TA, Gerald C (2001) Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A 98(16):8966-8971
2. Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60(6):1181-1188
3. Grandy DK (2007) Trace amine-associated receptor 1-family archetype or iconoclast? Pharmacol Ther 116(3):355-390
4. Lindemann L, Hoener MC (2005) A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci 26(5):274-281
5. Miller GM (2012) Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1). J Med Chem 55(5):1809-1814
6. Sotnikova TD, Caron MG, Gainetdinov RR (2009) Trace amine-associated receptors as emerging therapeutic targets. Mol Pharmacol 76(2):229-235
7. Pei Y, Lee JA, Leo D, Gainetdinov RR, Hoener MC, Canales JJ (2014) Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking. Neuropsychopharmacology 39:2299-2308
8. Bradaia A, Trube G, Stalder H, Norcross RD, Ozmen L, Wettstein JG, Pinard A, Buchy D, Gassmann M, Hoener MC, Bettler B (2009) The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci U S A 106:20081-20086
9. Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, Bettler B, Caron MG, Wettstein JG, Hoener MC (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci U S A 108(20):8485-8490
10. Revel FG, Moreau JL, Gainetdinov RR, Ferragud A, Velazquez-Sanchez C, Sotnikova TD, Morairty SR, Harmeier A, Groebke Zbinden K, Norcross RD, Bradaia A, Kilduff TS, Biemans B, Pouzet B, Caron MG, Canales JJ, Wallace TL, Wettstein JG, Hoener MC (2012) Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry 72(11):934-942
11. Revel FG, Moreau JL, Pouzet B, Mory R, Bradaia A, Buchy D, Metzler V, Chaboz S, Groebke Zbinden K, Galley G, Norcross RD, Tuerck D, Bruns A, Morairty SR, Kilduff TS, Wallace TL, Risterucci C, Wettstein JG, Hoener MC (2013) A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry 18(5):543-556
12. Thorn DA, Jing L, Qiu Y, Gancarz-Kausch AM, Galuska CM, Dietz DM, Zhang Y, Li JX (2014) Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats. Neuropsychopharmacology 39:2309-2316
13. Sandler M, Ruthven CR, Goodwin BL, Reynolds GP, Rao VA, Coppen A (1980) Trace amine deficit in depressive illness: the phenylalanine connexion. Acta Psychiatr Scand Suppl 280:29-39
14. Berry MD (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90(2):257-271
15. Boulton AA (1980) Trace amines and mental disorders. Can J Neurol Sci 7(3):261-263
16. Branchek TA, Blackburn TP (2003) Trace amine receptors as targets for novel therapeutics: legend, myth and fact. Curr Opin Pharmacol 3(1):90-97
17. Berry MD (2007) The potential of trace amines and their receptors for treating neurological and psychiatric diseases. Rev Recent Clin Trials 2(1):3-19
18. Liberles SD, Buck LB (2006) A second class of chemosensory receptors in the olfactory epithelium. Nature 442(7103):645-650
19. Sotnikova TD, Beaulieu JM, Espinoza S, Masri B, Zhang X, Salahpour A, Barak LS, Caron MG, Gainetdinov RR (2010) The dopamine metabolite 3-methoxytyramine is a neuromodulator. PLoS One 5(10):e13452
20. Yang HY, Neff NH (1973) Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther 187(2):365-371
21. Durden DA, Philips SR (1980) Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain. J Neurochem 34(6):1725-1732
22. Philips SR, Boulton AA (1979) The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum. J Neurochem 33(1):159-167
23. Grimsby J, Toth M, Chen K, Kumazawa T, Klaidman L, Adams JD, Karoum F, Gal J, Shih JC (1997) Increased stress response and beta-phenylethylamine in MAOB-deficient mice. Nat Genet 17(2):206-210
24. Juorio AV, Philips SR (1976) Arylalkylamines in Octopus tissues. Neurochem Res 1 (5):501-509
25. Robertson HA, Juorio AV (1976) Octopamine and some related noncatecholic amines in invertebrate nervous systems. Int Rev Neurobiol 19:173-224
26. Parker EM, Cubeddu LX (1988) Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding. J Pharmacol Exp Ther 245(1):199-210
27. Fuxe K, Grobecker H, Jonsson J (1967) The effect of beta-phenylethylamine on central and peripheral monoamine-containing neurons. Eur J Pharmacol 2(3):202-207
28. Raiteri M, Del Carmine R, Bertollini A, Levi G (1977) Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine. Eur J Pharmacol 41(2):133-143
29. Sotnikova TD, Budygin EA, Jones SR, Dykstra LA, Caron MG, Gainetdinov RR (2004) Dopamine transporter-dependent and -independent actions of trace amine betaphenylethylamine. J Neurochem 91(2):362-373
30. Wolinsky TD, Swanson CJ, Smith KE, Zhong H, Borowsky B, Seeman P, Branchek T, Gerald CP (2007) The trace amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav 6(7):628-639
31. Wainscott DB, Little SP, Yin T, Tu Y, Rocco VP, He JX, Nelson DL (2007) Pharmacologic characterization of the cloned human trace amine-associated receptor 1 (TAAR1) and evidence for species differences with the rat TAAR1. J Pharmacol Exp Ther 320(1):475-485
32. Navarro HA, Gilmour BP, Lewin AH (2006) A rapid functional assay for the human trace amine-associated receptor 1 based on the mobilization of internal calcium. J Biomol Screen 11 (6):688-693
33. Miller GM, Verrico CD, Jassen A, Konar M, Yang H, Panas H, Bahn M, Johnson R, Madras BK (2005) Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther 313(3):983-994
34. Lindemann L, Meyer CA, Jeanneau K, Bradaia A, Ozmen L, Bluethmann H, Bettler B, Wettstein JG, Borroni E, Moreau JL, Hoener MC (2008) Trace amine-associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther 324(3):948-956
35. Lewin AH, Navarro HA, Mascarella SW (2008) Structure-activity correlations for betaphenethylamines at human trace amine receptor 1. Bioorg Med Chem 16(15):7415-7423
36. Barak LS, Salahpour A, Zhang X, Masri B, Sotnikova TD, Ramsey AJ, Violin JD, Lefkowitz RJ, Caron MG, Gainetdinov RR (2008) Pharmacological characterization of membraneexpressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Mol Pharmacol 74(3):585-594
37. Zhang J, Pacifico R, Cawley D, Feinstein P, Bozza T (2013) Ultrasensitive detection of amines by a trace amine-associated receptor. J Neurosci 33(7):3228-3239
38. Babusyte A, Kotthoff M, Fiedler J, Krautwurst D (2013) Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2. J Leukoc Biol 93 (3):387-394
39. Lindemann L, Ebeling M, Kratochwil NA, Bunzow JR, Grandy DK, Hoener MC (2005) Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85(3):372-385
40. Duan J, Martinez M, Sanders AR, Hou C, Saitou N, Kitano T, Mowry BJ, Crowe RR, Silverman JM, Levinson DF, Gejman PV (2004) Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet 75(4):624-638
41. Xie Z, Miller GM (2007) Trace amine-associated receptor 1 is a modulator of the dopamine transporter. J Pharmacol Exp Ther 321(1):128-136
42. Pae CU, Drago A, Kim JJ, Patkar AA, Jun TY, De Ronchi D, Serretti A (2010) TAAR6 variations possibly associated with antidepressant response and suicidal behavior. Psychiatry Res 180(1):20-24
43. Wasik AM, Millan MJ, Scanlan T, Barnes NM, Gordon J (2012) Evidence for functional trace amine associated receptor-1 in normal and malignant B cells. Leuk Res 36(2):245-249
44. Panas MW, Xie Z, Panas HN, Hoener MC, Vallender EJ, Miller GM (2012) Trace amine associated receptor 1 signaling in activated lymphocytes. J Neuroimmune Pharmacol 7 (4):866-876
45. Chiellini G, Frascarelli S, Ghelardoni S, Carnicelli V, Tobias SC, DeBarber A, Brogioni S, Ronca-Testoni S, Cerbai E, Grandy DK, Scanlan TS, Zucchi R (2007) Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J 21 (7):1597-1608
46. Di Cara B, Maggio R, Aloisi G, Rivet JM, Lundius EG, Yoshitake T, Svenningsson P, Brocco M, Gobert A, De Groote L, Cistarelli L, Veiga S, De Montrion C, Rodriguez M, Galizzi JP, Lockhart BP, Coge F, Boutin JA, Vayer P, Verdouw PM, Groenink L, Millan MJ (2011) Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA). J Neurosci 31(47):16928-16940
47. Reese EA, Bunzow JR, Arttamangkul S, Sonders MS, Grandy DK (2007) Trace amineassociated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. J Pharmacol Exp Ther 321(1):178-186
48. Barak LS, Ferguson SS, Zhang J, Caron MG (1997) A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation. J Biol Chem 272 (44):27497-27500
49. Kim KM, Gainetdinov RR, Laporte SA, Caron MG, Barak LS (2005) G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation. J Biol Chem 280 (13):12774-12780
50. Xie Z, Westmoreland SV, Bahn ME, Chen GL, Yang H, Vallender EJ, Yao WD, Madras BK, Miller GM (2007) Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther 321(1):116-127
51. Asghar SJ, Tanay VA, Baker GB, Greenshaw A, Silverstone PH (2003) Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers. Hum Psychopharmacol 18(4):291-299
52. Bowyer JF, Young JF, Slikker W, Itzak Y, Mayorga AJ, Newport GD, Ali SF, Frederick DL, Paule MG (2003) Plasma levels of parent compound and metabolites after doses of either D-fenfluramine or D-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations. Neurotoxicology 24(3):379-390
53. Hart ME, Suchland KL, Miyakawa M, Bunzow JR, Grandy DK, Scanlan TS (2006) Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. J Med Chem 49(3):1101-1112
54. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK (2004) 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10(6):638-642
55. Tan ES, Groban ES, Jacobson MP, Scanlan TS (2008) Toward deciphering the code to aminergic G protein-coupled receptor drug design. Chem Biol 15(4):343-353
56. Frascarelli S, Ghelardoni S, Chiellini G, Vargiu R, Ronca-Testoni S, Scanlan TS, Grandy DK, Zucchi R (2008) Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors. Eur J Pharmacol 587(1-3):231-236
57. Snead AN, Miyakawa M, Tan ES, Scanlan TS (2008) Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites. Bioorg Med Chem Lett 18(22):5920-5922
58. Snead AN, Santos MS, Seal RP, Miyakawa M, Edwards RH, Scanlan TS (2007) Thyronamines inhibit plasma membrane and vesicular monoamine transport. ACS Chem Biol 2(6):390-398
59. Kehr W(1976) 3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 293(3):209-215
60. Rajput AH, Fenton ME, Di Paolo T, Sitte H, Pifl C, Hornykiewicz O (2004) Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off. Parkinsonism Relat Disord 10(4):221-226
61. Xuehong L, Grandy DK, Janowsky AJ (2014) Ractopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1. J Pharmacol Exp Ther 350:124-129
62. Tallman KR, Grandy DK (2012) A decade of pharma discovery delivers new tools targeting trace amine-associated receptor 1. Neuropsychopharmacology 37(12):2553-2554
63. Cichero E, Espinoza S, Gainetdinov RR, Brasili L, Fossa P (2013) Insights into the structure and pharmacology of the human trace amine-associated receptor 1 (hTAAR1): homology modelling and docking studies. Chem Biol Drug Des 81(4):509-516
64. Reese EA, Norimatsu Y, Grandy MS, Suchland KL, Bunzow JR, Grandy DK (2014) Exploring the determinants of trace amine-associated receptor 1’s functional selectivity for the stereoisomers of amphetamine and methamphetamine. J Med Chem 57(2):378-390
65. Sandler M, Reynolds GP (1976) Does phenylethylamine cause schizophrenia? Lancet 1 (7950):70-71
66. D’Andrea G, Terrazzino S, Fortin D, Cocco P, Balbi T, Leon A (2003) Elusive amines and primary headaches: historical background and prospectives. Neurol Sci 24(Suppl 2):S65-S67
67. Shirkande S, O’Reilly R, Davis B, Durden D, Malcom D (1995) Plasma phenylethylamine levels of schizophrenic patients. Can J Psychiatry 40(4):221
68. Potkin SG, Karoum F, Chuang LW, Cannon-Spoor HE, Phillips I, Wyatt RJ (1979) Phenylethylamine in paranoid chronic schizophrenia. Science 206(4417):470-471
69. Seeman P, Weinshenker D, Quirion R, Srivastava LK, Bhardwaj SK, Grandy DK, Premont RT, Sotnikova TD, Boksa P, El-Ghundi M, O’Dowd BF, George SR, Perreault ML, Mannisto PT, Robinson S, Palmiter RD, Tallerico T (2005) Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci U S A 102 (9):3513-3518
70. Millan MJ (2000) Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors. J Pharmacol Exp Ther 295(3):853-861
71. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38(8):1083-1152
72. Gardier AM, Malagie I, Trillat AC, Jacquot C, Artigas F (1996) Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam Clin Pharmacol 10(1):16-27
73. Leo D, Mus L, Espinoza S, Hoener MC, Sotnikova TD, Gainetdinov RR (2014) Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Neuropharmacology 81:283-291
74. Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS, Caron MG, Gainetdinov RR (2011) Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol Pharmacol 80(3):416-425
75. Xie Z, Westmoreland SV, Miller GM (2008) Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. J Pharmacol Exp Ther 325 (2):629-640
76. Xie Z, Miller GM (2009) Trace amine-associated receptor 1 as a monoaminergic modulator in brain. Biochem Pharmacol 78(9):1095-1104
77. Xie Z, Miller GM (2008) Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain. J Pharmacol Exp Ther 325(2):617-628
78. Sukhanov I, Espinoza S, Yakovlev DS, Hoener MC, Sotnikova TD, Gainetdinov RR (2014) TAAR1-dependent effects of apomorphine in mice. Int J Neuropsychopharmacol 17:1683-1693
79. Costall B, Naylor RJ, Nohria V (1978) Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity. Eur J Pharmacol 50(1):39-50
80. Sulzer D (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69(4):628-649
81. Achat-Mendes C, Lynch LJ, Sullivan KA, Vallender EJ, Miller GM (2012) Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1. Pharmacol Biochem Behav 101(2):201-207
82. Lynch LJ, Sullivan KA, Vallender EJ, Rowlett JK, Platt DM, Miller GM (2013) Trace amine associated receptor 1 modulates behavioral effects of ethanol. Subst Abuse 7:117-126
83. Fuchs RA, Branham RK, See RE (2006) Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen. J Neurosci 26(13):3584-3588
84. Thorn DA, Zhang C, Zhang Y, Li JX (2014) The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats. Neurosci Lett 566:67-71
85. Zucchi R, Chiellini G, Scanlan TS, Grandy DK (2006) Trace amine-associated receptors and their ligands. Br J Pharmacol 149(8):967-978
86. Panas HN, Lynch LJ, Vallender EJ, Xie Z, Chen GL, Lynn SK, Scanlan TS, Miller GM (2010) Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetaminelike psychostimulants in trace amine associated receptor 1 knockout mice. J Neurosci Res 88:1962-1969
87. Nelson DA, Tolbert MD, Singh SJ, Bost KL (2007) Expression of neuronal trace amineassociated receptor (TAAR) mRNAs in leukocytes. J Neuroimmunol 192(1-2):21-30
88. Meredith EJ, Holder MJ, Chamba A, Challa A, Drake-Lee A, Bunce CM, Drayson MT, Pilkington G, Blakely RD, Dyer MJ, Barnes NM, Gordon J (2005) The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential antitumor target for psychotropics. FASEB J 19(9):1187-1189
89. Chamba A, Holder MJ, Jarrett RF, Shield L, Toellner KM, Drayson MT, Barnes NM, Gordon J (2010) SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies. Leuk Res 34(8):1103-1106